SEC Form 4 · accession 0001104659-16-117764

Ophthotech Corp. · OPHT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

May 2, 2016

Accepted (ET)

May 4, 2016 · 5:36 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410939

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 2, 2016	M	22,060	$10.03	A	54,451	D
Common Stock^F2	May 2, 2016	S	17,421	$46.01	D	37,030	D
Common Stock^F3	May 2, 2016	S	4,639	$46.82	D	32,391	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F4	$10.03	May 2, 2016	M	22,060	D	—	Apr 25, 2023	Common Stock	22,060	102,724	D

F1The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015.
F2These shares were disposed of in multiple transactions on May 2, 2016 at actual sales prices ranging from $45.56 to $46.55 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3These shares were disposed of in multiple transactions on May 2, 2016 at actual sales prices ranging from $46.57 to $47.18 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.